Medicinal flowers. XXXVI.1) Acylated oleanane-type triterpene saponins with inhibitory effects on melanogenesis from the flower buds of Chinese Camellia japonica

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 6, 2012, Pages 752-758

  Nakamura, Seikou ^a   Fujimoto, Katsuyoshi ^a   Nakashima, Souichi ^a   Matsumoto, Takahiro ^a   Miura, Tomoko ^a   Uno, Kaoru ^a   Matsuda, Hisashi ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Camellia japonica; Medicinal flower; Melanogenesis inhibitor; Sanchakasaponin; Triterpene oligoglycoside

Indexed keywords

ARBUTIN; GLYCOSIDE; MELANIN; SANCHAKASAPONIN E; SANCHAKASAPONIN F; SANCHAKASAPONIN G; SANCHAKASAPONIN H; SAPONIN DERIVATIVE; SASANQUASAPONIN I; SASANQUASAPONIN II; TERNSTOEMIASIDE C; THEOPHYLLINE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; YUCHASAPONIN A;

ACYLATION; ARTICLE; CAMELLIA JAPONICA; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CHINA; CHINESE HERB; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; FLOWER; HETERONUCLEAR MULTIPLE BOND CORRELATION; IC 50; MELANOGENESIS; MELANOMA CELL; NONHUMAN; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 84862338901     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.60.752     Document Type: Article

References (23)

1. Part XXXV: Fujimoto K., Nakamura S., Nakashima S., Matsumoto T., Miura T., Uno K., Matsuda H., Yoshikawa M., Phytochemistry, submitted.
2. Yoshikawa M., Morikawa T., Yamamoto K., Kato Y., Nagatomo A., Matsuda H., J. Nat. Prod., 68, 1360-1365 (2005).
3. Yoshikawa M., Nakamura S., Kato Y., Matsuhira K., Matsuda H., Chem. Pharm. Bull., 55, 598-605 (2007).
4. Yoshikawa M., Wang T., Sugimoto S., Nakamura S., Nagatomo A., Matsuda H., Harima S., Yakugaku Zasshi, 128, 141-151 (2008).
5. Yoshikawa M., Sugimoto S., Nakamura S., Matsuda H., Chem. Pharm. Bull., 56, 1297-1303 (2008).
6. Sugimoto S., Yoshikawa M., Nakamura S., Matsuda H., Heterocycles, 78, 1023-1029 (2009).
7. Yoshikawa M., Sugimoto S., Kato Y., Nakamura S., Wang T., Yamashita C., Matsuda H., Chem. Biodivers., 6, 903-915 (2009).
8. Sugimoto S., Chi G., Kato Y., Nakamura S., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 57, 269-275 (2009).
9. Matsuda H., Nakamura S., Fujimoto K., Moriuchi R., Kimura Y., Ikoma N., Hata Y., Muraoka O., Yoshikawa M., Chem. Pharm. Bull., 58, 1617-1621 (2010).
10. Yoshikawa M., Morikawa T., Fujiwara E., Ohgushi T., Asao Y., Matsuda H., Heterocycles, 55, 1653-1657 (2001).
11. Yoshikawa M., Morikawa T., Asao Y., Fujiwara E., Nakamura S., Matsuda H., Chem. Pharm. Bull., 55, 606-612 (2007).
12. Shin M. H., Wang W., Nam K. I., Jo Y., Jung J. H., Im K. S., J. Nat. Prod., 66, 1351-1355 (2003).
13. Kitagawa I., Yoshikawa M., Kobayashi K., Imamura Y., Im K. S., Ikenishi Y., Chem. Pharm. Bull., 28, 296-300 (1980).
14. Yosioka I., Nishimura T., Matsuda A., Kitagawa I., Chem. Pharm. Bull., 18, 1610-1620 (1970).
15. Tanaka T., Nakashima T., Ueda T., Tomii K., Kouno I., Chem. Pharm. Bull., 55, 899-901 (2007).
16. 13C-NMR spectra of 1- 4 were assigned with the aid of distortionless enhancement by polarization transfer (DEPT), DQF COSY, heteronuclear multiple quantum coherence spectroscopy (HMQC), and HMBC experiments.
17. Yosioka I., Hino K., Matsuda A., Kitagawa I., Chem. Pharm. Bull., 20, 1499-1506 (1972).
18. Itokawa H., Sawada N., Yoshioka I., Tetrahedron Lett., 8, 597-601 (1967).
19. Kitagawa I., Kitazawa K., Yosioka I., Chem. Pharm. Bull., 16, 2304-2306 (1968).
20. Higuchi R., Komori T., Kawasaki T., Lassak E. V., Phytochemistry, 22, 1235-1237 (1983).
21. Matsuda H., Nakashima S., Oda Y., Nakamura S., Yoshikawa M., Bioorg. Med. Chem., 17, 6048-6053 (2009).
22. Nakashima S., Matsuda H., Oda Y., Nakamura S., Xu F., Yoshikawa M., Bioorg. Med. Chem., 18, 2337-2345 (2010).
23. Nakamura S., Chen G., Nakashima S., Matsuda H., Pei Y., Yoshikawa M., Chem. Pharm. Bull., 58, 690-695 (2010).